Sun Ok Song

Dr. Sun Ok Song


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
SSSun Ok Song
Sun Ok Song
CJChang Hee Jung
Chang Hee Jung
YSYoung Duk Song
Young Duk Song
Cheol-Young ParkCheol-Young Park
Cheol-Young Park
HKHyuk-Sang Kwon
Hyuk-Sang Kwon
BLByung Wan Lee
Byung Wan Lee
Song SO, et al. Diabetes Metab J. 2014 Oct;38(5):395-403. http://dx.doi.org/10.4093/dmj.2014.38.5.395

31 October 2020 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
HKHae Kyung Kim
Hae Kyung Kim
SSSun Ok Song
Sun Ok Song
JNJunghyun Noh
Junghyun Noh
IJIn-Kyung Jeong
In-Kyung Jeong
BLByung Wan Lee
Byung Wan Lee
Background: Big data reports related to diseases and health care for the Korean population have been published since the National Health Insurance Service (NHIS) and the Health Insurance Review & Assessment (HIRA) Service provided limited open access to their databases. Here, we reviewed the structure, content, and means of using data from the National Health Insurance (NHI) system for the benefit of Korean researchers and presented the latest publication trends in Korean healthcare data procured from the NHI and HIRA databases. Methods: Since 2013, researchers have been able to obtain nationwide population-based studies using the NHI and HIRA databases of the insured. We searched publications using the NHI and the HIRA databases between 2013 and 2019 retrieved from PubMed. Results: The NHI and HIRA databases provide nationwide population-based data. The total number of publications from 2014 to 2019 using NHI and HIRA databases is 2,541 and 655, respectively. A total of 5,465 endocrinology-related studies were performed during 2014 to 2019. Conclusion: The NHIS and HIRA databases have provided tools for guidelines to approach world-leading population-based epidemiology and disease research.

1 January 2016 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
SSSun Ok Song
Sun Ok Song
YSYoung Duk Song
Young Duk Song
JNJoo Young Nam
Joo Young Nam
KPKyeong Hye Park
Kyeong Hye Park
JYJi-Hae Yoon
Ji-Hae Yoon
DLDong-Ha Lim
Dong-Ha Lim
The aim of this study was to estimate the prevalence and incidence of type 1 diabetes mellitus (T1DM) in Korea. In addition, we planned to do a performance analysis of the Registration Project of Type 1 diabetes for the reimbursement of consumable materials. To obtain nationwide data on the incidence and prevalence of T1DM, we extracted claims data from July 2011 to August 2013 from the Registration Project of Type 1 diabetes on the reimbursement of consumable materials in the National Health Insurance (NHI) Database. For a more detailed analysis of the T1DM population in Korea, stratification by gender, age, and area was performed, and prevalence and incidence were calculated. Of the 8,256 subjects enrolled over the 26 months, the male to female ratio was 1 to 1.12, the median age was 37.1 years, and an average of 136 new T1DM patients were registered to the T1DM registry each month, resulting in 1,632 newly diagnosed T1DM patients each year. We found that the incidence rate of new T1DM cases was 3.28 per 100,000 people. The average proportion of T1DM patients compared with each region's population was 0.0125%. The total number of insurance subscribers under the universal compulsory NHI in Korea was 49,662,097, and the total number of diabetes patients, excluding duplication, was 3,762,332. The prevalence of T1DM over the course of the study was approximately 0.017% to 0.021% of the entire population of Korea, and the annual incidence of T1DM was 3.28:100,000 overall and 3.25:100,000 for Koreans under 20 years old.

1 December 2012 in Atherosclerosis
Verified
Journal Article
Closed access
SSSun Ok Song
Sun Ok Song
KKKwang Joon Kim
Kwang Joon Kim
BLByung Wan Lee
Byung Wan Lee
EKEun Seok Kang
Eun Seok Kang
BCBong-Soo Cha
Bong-Soo Cha
HLHyun Chul Lee
Hyun Chul Lee

13 July 2012 in Autophagy
Verified
Journal Article
Open access
PDF file
YSYoung Mi Song
Young Mi Song
SSSun Ok Song
Sun Ok Song
YJYong-keun Jung
Yong-keun Jung
EKEun Seok Kang
Eun Seok Kang
BCBong-Soo Cha
Bong-Soo Cha
BLByung Wan Lee
Byung Wan Lee
Induction of autophagy is known not only to regulate cellular homeostasis but also to decrease triglyceride accumulation in hepatocytes. The aim of this study is to investigate whether DMSO (dimethyl sulfoxide) has a beneficial role in free fatty acid-induced hepatic fat accumulation. In HepG2 cells, treatment with 0.5 mM palmitate for six hours significantly increased lipid and triglyceride (TG) accumulation, assessed by Oil-red O staining and TG quantification assay. Treatment with 0.01% DMSO for 16 h statistically reduced palmitate-induced TG contents. Pretreatment of 10 mM 3-methyladenine (3MA) for 2 h restored hepatocellular lipid contents, which were attenuated by treatment with DMSO. DMSO increased LC3-II conversion and decreased SQSTM1/p62 expression in a time and dose-dependent manner. In addition, the number of autophagosomes and autolysosomes, as seen under an electron microscopy, as well as the percentage of RFP-LAMP1 colocalized with GFP-LC3 dots in cells transfected with both GFP-LC3 and RFP-LAMP1, as seen under a fluorescent microscopy, also increased in DMSO-treated HepG2 cells. DMSO also suppressed p-eIF2α/p-EIF2S1, ATF4, p-AKT1, p-MTOR and p-p70s6k/p-RPS6KB2 expression as assessed by western blotting. Knockdown of ATF4 expression using siRNA suppressed ATF4 expression and phosphorylation of AKT1, MTOR and RPS6KB2, but increased LC3-II conversion. DMSO reduced not only soluble but also insoluble mtHTT (mutant huntingtin aggregates) expressions, which were masked in the presence of autophagy inhibitor. DMSO, a kind of chemical chaperone, activated autophagy by suppressing ATF4 expression and might play a protective role in the development of fatty acid-induced hepatosteatosis.

1 January 2016 in Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
SSSun Ok Song
Sun Ok Song
YLYong-ho Lee
Yong-ho Lee
DKDong Wook Kim
Dong Wook Kim
YSYoung Duk Song
Young Duk Song
JNJoo Young Nam
Joo Young Nam
BLByung Wan Lee
Byung Wan Lee
Epidemiological data is useful to estimate the necessary manpower and resources used for disease control and prevention of prevalent chronic diseases. We aimed to evaluate the incidence of diabetes and identify its trends based on the claims data from the National Health Insurance Service database over the last decade. We extracted claims data on diabetes as the principal and first additional diagnoses of National Health Insurance from January 2003 to December 2012. We investigated the number of newly claimed subjects with diabetes codes, the number of claims and the demographic characteristics of this population. Total numbers of claimed cases and populations with diabetes continuously increased from 1,377,319 in 2003 to 2,571,067 by 2012. However, the annual number of newly claimed diabetic subjects decreased in the last decade. The total number of new claim patients with diabetes codes decreased as 30.9% over 2005 to 2009. Since 2009, the incidence of new diabetes claim patients has not experienced significant change. The 9-year average incidence rate was 0.98% and 1.01% in men and women, respectively. The data showed an increasing proportion of new diabetic subjects of younger age (<60 years) combined with a sharply decreasing proportion of subjects of older age (≥60 years). There were increasing numbers of newly claimed subjects with diabetes codes of younger age over the last 10 years. This increasing number of diabetic patients will require management throughout their life courses because Korea is rapidly becoming an aging society.